RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
+20.41%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$184M
AUM Growth
+$184M
(-25%)
Cap. Flow
-$117M
Cap. Flow
% of AUM
-63.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$97.1M |
| 2 |
Cytokinetics
CYTK
|
$20.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $108M | 52.6% |
1,111,111
-1,000,000
| -47% | -$97.1M |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $76.2M | 37.14% |
9,166,667
| – | – |
|
|
VIRX
3
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $42K | 0.02% |
3,700
| – | – |
|
|
4
Cytokinetics
CYTK
$4.23B
| – | – |
-875,656
| Closed | -$20.4M |
|